Last edition
News about
Abbott, the global healthcare company has announced the introduction of a room-temperature-stable, single-dose formulation of carbetocin in India, which is available in convenient vials, to help in the prevention of postpartum haemorrhage (PPH). Abbott's product is available in the private sector
Acute shortage of equipments faced by pharma cos: Infomerics
The report reveals that the steep 50 per cent rise in the cost of active pharmaceutical ingredients (API) is pinching the industry hard and raises doubts on the availability of drugs and could lead to shortages, particularly of those that are key in Covid therapy
Dr Reddy's and Zydus Pharma recall products in US market
Dr Reddy's Laboratories and Zydus Pharma are recalling bottles of a product each, in the US market, for different reasons, according to the latest report of the US health regulator. Dr Reddy's Laboratories is recalling 37,560 bottles of Tizanidine HCl tablets, USP 4 mg, the latest enforcement report by the US Food and Drug Administration (USFDA) said
Vivera Pharma's ZICOH technology receives second US patent for smart inhaler device
Vivera Pharmaceuticals, an innovative, science-driven pharmaceutical company located in Southern California, has announced that the US Patent and Trademark Office (USPTO) has granted its ZICOH technology a second US Patent, No. 11,090,449
CDSCO issues pathway for regularisation of 19 FDCs out of 294 which require further data
The Central Drugs Standard Control Organisation (CDSCO) has issued a pathway for regularisation of 19 fixed dose combinations (FDCs) out of the 294 FDCs which require further generation of data and were licensed by State Licensing Authority (SLA) without prior approval from the Drugs Controller General (India)
Indian vaccine manufacturers face a crucial shortage of equipment including small- and large-scale bioreactors and fermenters, a report "Pharma Industry: Trends and Prospects" from Infomerics Valuation and Rating revealed
J B Chemicals & Pharmaceuticals stated that it will continue investing and strengthening portfolio in the cardiology and hypertension space and will continue to launch products in the area of anti-allergy, oral corticosteroids, cough & cold and nicotine replacement therapies
Nucleome unveils South Asia's largest genomics research centre in Hyderabad
In a move that will mark the beginning of a new era in India's genomics capability, Nucleome Informatics has unveiled South Asia's largest and most advanced genomics facility, NKC Centre for Genomics Research in Hyderabad
ICMR invites proposals for providing clinical trials liability insurance for SOLIDARITY PLUS trial
ICMR through ICMR-National AIDS Research Institute, Pune is coordinating a trial, titled "An international randomized trial of additional treatments for Covid-19 in hospitalized patients who are all receiving the local standard of care SOLIDARITY TRIAL PLUS" or World Health Organization (WHO)-India (ICMR) SOLIDARITY trial plus
Wockhardt arm partners with Jemincare for novel respiratory antibiotic nafithromycin
Wockhardt Bio AG - a subsidiary of Wockhardt Limited, a worldwide leader in discovery of novel antibiotics and Jiangxi Jemincare Group Company Limited, China, have partnered for Wockhardt's novel patented antibiotic WCK 4873 (nafithromycin) in People's Republic of China, Hong Kong, Macau and Taiwan for the treatment of community-acquired bacterial
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy